To more precisely study the potential role of ERBB2 in signalling through AP-1 in OAC, we compared the accessible chromatin landscape of three ERBB2 amplified OAC tumours to Barrett's oesophageal samples (the precursor to OAC) and nine OAC samples lacking such amplifications (Supplementary Figure S3A). The gene discussed is FOS; the disease is neoplasm.